David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $20.3M | 0.03% |
+184,285
| New | +$19.9M |
|
|
PE
702
DELISTED
PARSLEY ENERGY INC
PE
| $20.3M | 0.03% |
1,050,685
-1,039,138
| -50% | -$19.1M |
|
|
WMGI
703
DELISTED
Wright Medical Group Inc
WMGI
| $20.3M | 0.03% |
644,751
+213,792
| +50% | +$6.49M |
|
|
PDCO
704
DELISTED
Patterson Companies, Inc.
PDCO
| $20.3M | 0.03% |
926,902
+310,513
| +50% | +$6.88M |
|
|
GWPH
705
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $20.2M | 0.03% |
119,756
+97,525
| +439% | +$14.5M |
|
706
Nutanix
NTNX
$18B
| $20.2M | 0.03% |
534,309
-2,518,657
| -82% | -$115M |
|
707
PUT
Palo Alto Networks
PANW
$286B
| $20.1M | 0.03% |
497,400
-37,800
| -7% | -$1.4M |
|
708
Usana Health Sciences
USNA
$251M
| $20.1M | 0.03% |
240,047
+126,466
| +111% | +$13.2M |
|
709
PUT
Marathon Petroleum
MPC
$102B
| $20M | 0.03% |
334,800
-56,400
| -14% | -$3.55M |
|
|
SFIX
710
Stitch Fix
SFIX
$439M
| $20M | 0.03% |
+708,964
| New | +$17.6M |
|
711
Unum
UNM
$14.2B
| $20M | 0.03% |
591,064
+524,788
| +792% | +$18.3M |
|
712
Pan American Silver
PAAS
$22.2B
| $20M | 0.03% |
1,506,075
+1,466,408
| +3,697% | +$20.5M |
|
|
PRSP
713
DELISTED
Perspecta Inc. Common Stock
PRSP
| $20M | 0.03% |
986,924
+136,691
| +16% | +$2.75M |
|
714
Deluxe
DLX
$1.1B
| $19.9M | 0.03% |
454,366
+185,835
| +69% | +$8.34M |
|
715
OraSure Technologies
OSUR
$263M
| $19.8M | 0.03% |
1,778,157
+920,123
| +107% | +$10.7M |
|
716
American Financial Group
AFG
$12B
| $19.8M | 0.03% |
205,908
+46,859
| +29% | +$4.49M |
|
|
LTRPA
717
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $19.7M | 0.03% |
1,391,266
-256,952
| -16% | -$4.05M |
|
718
PUT
eBay
EBAY
$47.7B
| $19.6M | 0.03% |
527,300
-148,900
| -22% | -$5.17M |
|
719
PUT
Chevron
CVX
$398B
| $19.6M | 0.03% |
158,800
-215,100
| -58% | -$25.4M |
|
720
SM Energy
SM
$8.67B
| $19.5M | 0.03% |
1,115,736
-179,125
| -14% | -$3.18M |
|
721
Travere Therapeutics
TVTX
$6.15B
| $19.4M | 0.03% |
858,589
+81,069
| +10% | +$1.79M |
|
|
PINC
722
DELISTED
Premier
PINC
| $19.4M | 0.03% |
561,535
+300,748
| +115% | +$11.1M |
|
723
Perrigo
PRGO
$1.98B
| $19.3M | 0.02% |
400,788
-17,128
| -4% | -$802K |
|
724
Louisiana-Pacific
LPX
$5.08B
| $19.3M | 0.02% |
791,673
+190,690
| +32% | +$4.66M |
|
725
Puma Biotechnology
PBYI
$471M
| $19.2M | 0.02% |
495,226
+425,991
| +615% | +$13M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.